Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Accumulated Depreciation (2020 - 2025)

BioAtla (BCAB) has disclosed Accumulated Depreciation for 6 consecutive years, with $5.3 million as the latest value for Q4 2025.

  • For Q4 2025, Accumulated Depreciation fell 24.2% year-over-year to $5.3 million; the TTM value through Dec 2025 reached $5.3 million, down 24.2%, while the annual FY2025 figure was $5.3 million, 24.2% down from the prior year.
  • Accumulated Depreciation hit $5.3 million in Q4 2025 for BioAtla, down from $7.4 million in the prior quarter.
  • Across five years, Accumulated Depreciation topped out at $7.4 million in Q3 2025 and bottomed at $3.4 million in Q1 2021.
  • Average Accumulated Depreciation over 5 years is $5.6 million, with a median of $5.8 million recorded in 2023.
  • Year-over-year, Accumulated Depreciation surged 38.66% in 2021 and then dropped 24.2% in 2025.
  • BioAtla's Accumulated Depreciation stood at $4.3 million in 2021, then grew by 26.0% to $5.4 million in 2022, then increased by 13.31% to $6.1 million in 2023, then increased by 15.22% to $7.0 million in 2024, then decreased by 24.2% to $5.3 million in 2025.
  • According to Business Quant data, Accumulated Depreciation over the past three periods came in at $5.3 million, $7.4 million, and $7.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.